A recent Texas poll found that 75% of voters support medical cannabis reforms, KTAL reports.

The survey by Fabrizio, Lee & Associates found that while three-quarters of respondents said they support the legalization of medical cannabis in general, only 11% said they had previously heard of the Texas Compassionate Use Program (TCUP), which state lawmakers passed in 2015 to grant limited access to cannabinoid-based products.

Of the 1,000 respondents, 44% said they would be more likely to vote for a legislator who supported TCUP, while only 13% said they would be less likely to vote for them.

Meanwhile, Texas lawmakers passed a new law last year expanding the TCUP to increase the number of licensed operators and allow new methods of consumption, including the distribution of vaporized or aerosolized medical cannabis, while smoking remains prohibited. The expansions also included adding traumatic brain injury, chronic pain and any terminal illness or condition requiring hospice as qualifying conditions for the program.

The poll, which was designed to gauge voter reaction to the TCUP expansions, found that 63% of Texas Republicans support legalizing medical cannabis.

The US House of Representatives voted 224-200 on Tuesday to approve the federal farm bill, which contains some hemp-related provisions but excludes language to delay or reverse expected federal changes to hemp-derived THC this November. of reports.

The US first legalized industrial hemp through the 2018 Farm Bill, which was passed during President Trump’s first term. The original legalization language covered the hemp plant and all its derivatives, as long as the crop contained less than 0.3% THC. The changes allowed a national gray market for hemp-derived cannabinoids that quickly grew into a multibillion-dollar industry as operators established methods of converting hemp-derived CBD to delta-8 THC and other intoxicating cannabinoids.

But the industry was plunged into uncertainty last year when President Trump signed a spending bill that contained language to shut down the sale of intoxicating hemp products nationwide.

According to the report, the hemp provisions in the Farm, Food, and Homeland Security Act of 2026 seek to clarify regulations and reduce the burden faced by industrial hemp farmers in the US.

The farm bill moves to the Senate for consideration, where advocates hope lawmakers will propose protections for the sunset hemp industry.

Unless Congress passes any changes or exemptions to the rules, the current hemp cannabinoid industry will effectively end on November 12, 2026.

Missouri Governor Mike Kehoe (R) last week signed into law the Intoxicating Cannabinoid Control Act. In a statement, the governor said “the legislation ensures that Missourians know that products sold in their communities are safe, regulated and kept out of the reach of children.”

“For too long, bad actors have exploited loopholes to market intoxicating products — including candy-like candy or similar products — without meaningful oversight or accountability.” – Kehoe, in one press release

The bill aligns the state definition of hemp with the new federal definition, bringing the regulation of hemp-derived cannabinoid products under existing cannabis regulations.

President Donald Trump (R) on Nov signed an expense bill which included new federal regulations on hemp products that effectively criminalize hemp-derived THC and redefine hemp as “grown for the use of the whole grain, oil, cake, nut, husk, or any other non-cannabinoid compound, derivative, mixture, preparation or manufacture of the seed” and “grown for the purpose of human consumption or other products made from its flesh.” an immature hemp plant grown from seeds that do not exceed” 0.3% THC. The new regime will take effect this November.

Missouri law requires unlicensed entities to cease manufacturing or selling hemp-derived cannabinoid products.

The bill also prohibits cannabis distributors or other authorized parties from keeping records or sharing identifying information of regulated consumers of cannabis products, unless the consumer consents to the creation or retention of records in writing.